News
Please browse our press releases below. These are all in Adobe Acrobat PDF format. If you do not have an appropriate PDF reader, please click here
ProStrakan Announces Canadian Regulatory Filing of Abstral
Allan Watson Receives Investor Relations Award
ProStrakan Announces FDA Acceptance of US Submission of Cellegesic™ (nitroglycerin) 0.4% Ointment
ProStrakan Announces FDA Acceptance of Abstral Filing
Dealing by Directors and Persons Discharging Managerial Responsibilities
ProStrakan Partners with Endo for Fortigel (FORTESTA) in the US
26th August 2009
Click here to download press release
Interim Results for the Six Months Ended 30 June 2009
20th August 2009
Click here to download press release
ProStrakan Announces Upcoming Launch of Abstral in France
30th June 2009
Click here to download press release
ProStrakan Announces Publication of Notice of Allowance for Sancuso US Patent
25th June 2009
Click here to download press release
Results of Resolutions Passed at Annual General Meeting
20th May 2009
Annual information update for period 23 May 2008 up to and including 15 May 2009
15th May 2009
ProStrakan Announces US Submission of Fortigel (testosterone) 2% Gel
5th May 2009
ProStrakan Announces US Co-Promotion Agreement for Oncology Support Product, Gelclair
18th March 2009
Abstral Receives Marketing Approval in France and Spain
2nd March 2009
Preliminary Results for Year Ended 31 December 2008
18th March 2009
ProStrakan Announces Further Outlicensing Deals in Globalisation of Sancuso
9th February 2009
Change of announcement date for 2008 Preliminary Results
